InterCure (NASDAQ:INCR – Get Free Report) and Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.
Risk & Volatility
InterCure has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, Green Thumb Industries has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings for InterCure and Green Thumb Industries, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InterCure | 1 | 0 | 0 | 0 | 1.00 |
| Green Thumb Industries | 0 | 1 | 1 | 1 | 3.00 |
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InterCure | $64.55 million | N/A | -$18.32 million | $0.08 | 11.54 |
| Green Thumb Industries | $1.14 billion | 1.21 | $73.08 million | $0.17 | 39.18 |
Green Thumb Industries has higher revenue and earnings than InterCure. InterCure is trading at a lower price-to-earnings ratio than Green Thumb Industries, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares InterCure and Green Thumb Industries’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InterCure | N/A | N/A | N/A |
| Green Thumb Industries | 3.77% | 1.66% | 1.17% |
Institutional and Insider Ownership
8.3% of InterCure shares are owned by institutional investors. Comparatively, 0.1% of Green Thumb Industries shares are owned by institutional investors. 0.2% of InterCure shares are owned by insiders. Comparatively, 9.4% of Green Thumb Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Green Thumb Industries beats InterCure on 11 of the 13 factors compared between the two stocks.
About InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
About Green Thumb Industries
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
